cannabis indica

Índice completo — página 19 de 77

Estudos 1.801 a 1.900 de 7.640, ordenados do mais recente ao mais antigo — nesta página, publicações de 2021. Para buscar por termo ou combinar filtros, use o acervo com busca.

Estudos 1.801 a 1.900

  1. 2021

    Cannabidiol inhibits human glioma by induction of lethal mitophagy through activating TRPV4

    FavorávelEstudo em AnimaisCâncerCâncer — Cérebro
  2. 2021

    Cannabidiol Inhibits In Vitro Human Liver Microsomal Metabolism of Remdesivir: A Promising Adjuvant for COVID-19 Treatment

    FavorávelEstudo LaboratorialCOVID-19
  3. 2021

    Cannabidiol Inhibits SARS-CoV-2 Replication and Promotes the Host Innate Immune Response

    FavorávelEstudo LaboratorialCâncerInflamaçãoCOVID-19Canabigerol (CBG)Canabicromeno (CBC)+2
  4. 2021

    Cannabidiol inhibits SARS-Cov-2 spike (S) protein-induced cytotoxicity and inflammation through a PPARγ-dependent TLR4/NLRP3/Caspase-1 signaling suppression in Caco-2 cell line

    FavorávelEstudo LaboratorialCOVID-19
  5. 2021

    Cannabidiol Interactions with Medications, Illicit Substances, and Alcohol: a Comprehensive Review

    DesfavorávelMetanáliseDepressãoEpilepsiaDependência — OpioidesCBD Farmacêutico+4
  6. 2021

    Cannabidiol Isolated From Cannabis sativa L. Protects Intestinal Barrier From In Vitro Inflammation and Oxidative Stress

    FavorávelEstudo LaboratorialInflamaçãoEstresse OxidativoDII — Doença Inflamatória IntestinalÁcido Canabidiólico (CBD-a)Ácido Tetraidrocanabinólico (THC-a)
  7. 2021

    Cannabidiol loaded extracellular vesicles sensitize triple-negative breast cancer to doxorubicin in both in-vitro and in vivo models

    FavorávelEstudo LaboratorialCâncerInflamaçãoCâncer — Mama
  8. 2021

    Cannabidiol microinjection into the nucleus accumbens attenuated nociceptive behaviors in an animal model of tonic pain

    FavorávelEstudo em AnimaisDorInflamaçãoDor — Crônica
  9. 2021

    Cannabidiol modifies the seizure expression and effects of antiseizure drugs in a rat model of recurrent severe seizures

    FavorávelEstudo em AnimaisEpilepsia
  10. 2021

    Cannabidiol Modulates Mitochondrial Redox and Dynamics in MCF7 Cancer Cells: A Study Using Fluorescence Lifetime Imaging Microscopy of NAD(P)H

    InconclusivoEstudo LaboratorialCâncerEstresse Oxidativo
  11. 2021

    Cannabidiol Modulates the Motor Profile and NMDA Receptor-related Alterations Induced by Ketamine

    InconclusivoEstudo em AnimaisEsquizofrenia
  12. 2021

    Cannabidiol modulation of hippocampal glutamate in early psychosis

    FavorávelEnsaio Clínico Duplo-CegoPsicoseEsquizofreniaDependência — Estimulantes
  13. 2021

    Cannabidiol modulation of oxidative stress and signalling

    FavorávelMetanáliseEstresse Oxidativo
  14. 2021

    Cannabidiol oxidation product HU-331 is a potential anticancer cannabinoid-quinone: a narrative review

    FavorávelMetanáliseCâncerCanabinoides Sintéticos HU-x
  15. 2021

    Cannabidiol prevents amphetamine relapse and modulates D1- and D2-receptor levels in mesocorticolimbic brain areas of rats

    FavorávelEstudo em AnimaisDependência QuímicaDependência — Estimulantes
  16. 2021

    Cannabidiol prevents disruptions in sensorimotor gating induced by psychotomimetic drugs that last for 24-h with probable involvement of epigenetic changes in the ventral striatum

    FavorávelEstudo em AnimaisPsicoseEsquizofrenia
  17. 2021

    Cannabidiol prevents lipopolysaccharide-induced sickness behavior and alters cytokine and neurotrophic factor levels in the brain

    FavorávelEstudo em AnimaisInflamaçãoDepressãoDoenças Neurodegenerativas
  18. 2021

    Cannabidiol prevents priming- and stress-induced reinstatement of the conditioned place preference induced by cocaine in mice

    FavorávelEstudo em AnimaisDependência QuímicaDependência — Cocaína
  19. 2021

    Cannabidiol prevents several of the behavioral alterations related to cocaine addiction in mice

    FavorávelEstudo em AnimaisDependência QuímicaDependência — Cocaína
  20. 2021

    Cannabidiol Product Dosing and Decision-Making in a National Survey of Individuals with Fibromyalgia

    FavorávelMetanáliseFibromialgia
  21. 2021

    Cannabidiol promotes neurogenesis in the dentate gyrus during an abstinence period in rats following chronic exposure to methamphetamine

    FavorávelEstudo em AnimaisDependência QuímicaDependência — EstimulantesEfeitos Adversos do MDMA
  22. 2021

    Cannabidiol Protects Human Skin Keratinocytes from Hydrogen-Peroxide-Induced Oxidative Stress via Modulation of the Caspase-1-IL-1β Axis

    FavorávelEstudo LaboratorialEstresse Oxidativo
  23. 2021

    Cannabidiol reduces lesion volume and restores vestibulomotor and cognitive function following moderately severe traumatic brain injury

    FavorávelEstudo em AnimaisInflamaçãoTraumatismo Cranioencefálico
  24. 2021

    Cannabidiol reduces soman-induced lethality and seizure severity in female plasma carboxylesterase knockout mice treated with midazolam

    FavorávelEstudo em AnimaisEpilepsia
  25. 2021

    Cannabidiol reduces withdrawal symptoms in nicotine-dependent rats

    FavorávelEstudo em AnimaisDependência QuímicaDependência — Nicotina
  26. 2021

    Cannabidiol regulates CB1-pSTAT3 signaling for neurite outgrowth, prolongs lifespan, and improves health span in Caenorhabditis elegans of Aβ pathology models

    FavorávelEstudo em AnimaisDoença de Alzheimer
  27. 2021

    Cannabidiol Selectively Binds to the Voltage-Gated Sodium Channel Nav1.4 in Its Slow-Inactivated State and Inhibits Sodium Current

    FavorávelEstudo LaboratorialDistrofia Muscular e Distúrbios Miotônicos
  28. 2021

    Cannabidiol selectively inhibits the contraction of rat small resistance arteries: Possible role for CGRP and voltage-gated calcium channels

    FavorávelEstudo LaboratorialDoenças Cardiovasculares (DCV)
  29. 2021

    Cannabidiol Signaling in the Eye and Its Potential as an Ocular Therapeutic Agent

    FavorávelMetanáliseDorInflamaçãoEstresse Oxidativo+5
  30. 2021

    Cannabidiol Therapy for Refractory Epilepsy and Seizure Disorders

    FavorávelMetanáliseEpilepsia
  31. 2021

    Cannabidiol treatment of severe refractory epilepsy in children and young adults

    FavorávelMetanáliseEpilepsiaEpilepsia — Síndrome de DravetEpilepsia — Lennox-Gastaut
  32. 2021

    Cannabidiol Treatment Results in a Common Gene Expression Response Across Aggressive Cancer Cells from Various Origins

    FavorávelEstudo LaboratorialCâncerCâncer — MamaCâncer — Cérebro+3
  33. 2021

    Cannabidiol use and effectiveness: real-world evidence from a Canadian medical cannabis clinic

    FavorávelMetanáliseDorAnsiedadeDepressão
  34. 2021

    Cannabidiol Use for Fibromyalgia: Prevalence of Use and Perceptions of Effectiveness in a Large Online Survey

    FavorávelMetanáliseFibromialgia
  35. 2021

    Cannabidiol Use, Substitution for Medications, and Perceptions of Effectiveness in Women with Chronic Pelvic Pain

    FavorávelMetanáliseDorEfeitos Adversos da CannabisAnsiedade+9
  36. 2021

    Cannabidiol versus risperidone for treatment of recent-onset psychosis with comorbid cannabis use: study protocol for a randomized controlled clinical trial

    InconclusivoEnsaio Clínico Duplo-CegoDependência QuímicaDependência — CannabisPsicose
  37. 2021

    Cannabidiol-based natural health products for companion animals: Recent advances in the management of anxiety, pain, and inflammation

    FavorávelMetanáliseDorInflamaçãoAnsiedade+5
  38. 2021

    Cannabidiol-dihydroartemisinin conjugates for ameliorating neuroinflammation with reduced cytotoxicity

    FavorávelEstudo LaboratorialInflamação
  39. 2021

    Cannabidiol-Driven Alterations to Inflammatory Protein Landscape of Lipopolysaccharide-Activated Macrophages In Vitro May Be Mediated by Autophagy and Oxidative Stress

    FavorávelEstudo LaboratorialInflamaçãoEstresse Oxidativo
  40. 2021

    Cannabidiol-enriched medical cannabis as add-on therapy in children with treatment-resistant West syndrome: A study of eight patients

    FavorávelEnsaio ClínicoEpilepsia
  41. 2021

    Cannabidiol-enriched oil in children and adults with treatment-resistant epilepsy-does tolerance exist?

    DesfavorávelMetanáliseEpilepsia
  42. 2021

    Cannabidiol-induced activation of the metallothionein pathway impedes anticancer effects of disulfiram and its metabolite CuET

    DesfavorávelEstudo LaboratorialCâncer
  43. 2021

    Cannabidiol‐mediated RISK PI3K/AKT and MAPK/ERK pathways decreasing reperfusion myocardial damage

    FavorávelEstudo em AnimaisDoenças Cardiovasculares (DCV)Infarto
  44. 2021

    Cannabidiol: pharmacology and therapeutic targets

    FavorávelMetanáliseDorInflamaçãoDor — Crônica+5
  45. 2021

    Cannabidiolic acid exhibits entourage-like improvements of anticonvulsant activity in an acute rat model of seizures

    FavorávelEstudo em AnimaisEpilepsiaÁcido Canabidiólico (CBD-a)
  46. 2021

    Cannabigerol and cannabichromene in Cannabis sativa L.

    FavorávelMetanáliseCâncerInflamaçãoAnsiedadeAnandamida (AEA)2-Araquidonoilglicerol (2-AG)+13
  47. 2021

    Cannabigerol Is a Potential Therapeutic Agent in a Novel Combined Therapy for Glioblastoma

    FavorávelEstudo LaboratorialCâncerCâncer — CérebroCanabigerol (CBG)
  48. 2021

    Cannabigerolic acid, a major biosynthetic precursor molecule in cannabis, exhibits divergent effects on seizures in mouse models of epilepsy

    FavorávelEstudo em AnimaisEpilepsiaEpilepsia — Síndrome de DravetÁcido Canabigerólico (CBG-a)
  49. 2021

    Cannabinoid Activity-Is There a Causal Connection to Spasmolysis in Clinical Studies?

    InconclusivoMetanálise ClínicaDor
  50. 2021

    Cannabinoid and Opioid Use Among Total Joint Arthroplasty Patients: A 6-Year, Single-Institution Study

    FavorávelMetanáliseDorDependência QuímicaDor — Crônica+3
  51. 2021

    Cannabinoid control of gingival immune activation in chronically SIV-infected rhesus macaques involves modulation of the indoleamine-2,3-dioxygenase-1 pathway and salivary microbiome

    FavorávelEstudo em AnimaisInflamaçãoInfecções BacterianasHIV/AIDSMicrobioma+1
  52. 2021

    Cannabinoid control of hippocampal functions: the where matters

    FavorávelMetanáliseInflamaçãoEpilepsiaDisfunção CognitivaAnandamida (AEA)Endocanabinoide (não especificado)+7
  53. 2021

    Cannabinoid exposure as a major driver of pediatric acute lymphoid Leukaemia rates across the USA: combined geospatial, multiple imputation and causal inference study

    DesfavorávelMetanáliseCâncerAlterações Cerebrais NeonataisCâncer — LeucemiaCanabigerol (CBG)Canabinol (CBN)+1
  54. 2021

    Cannabinoid hyperemesis syndrome can be relieved by warm baths

    DesfavorávelMetanáliseDorEfeitos Adversos da CannabisDependência — Cannabis+3
  55. 2021

    Cannabinoid Hyperemesis Syndrome in an Athlete

    DesfavorávelMetanáliseSíndrome da Hiperêmese Canabinoide
  56. 2021

    Cannabinoid Hyperemesis Syndrome in Pediatrics: An Emerging Problem

    DesfavorávelMetanáliseSíndrome da Hiperêmese Canabinoide
  57. 2021

    Cannabinoid Hyperemesis Syndrome Secondary to Delta-8 THC Use

    DesfavorávelMetanáliseEfeitos Adversos da CannabisDependência — OpioidesNáusea e VômitoDelta-8-THC+1
  58. 2021

    Cannabinoid Hyperemesis Syndrome Survey and Genomic Investigation

    DesfavorávelMetanáliseSíndrome da Hiperêmese Canabinoide
  59. 2021

    Cannabinoid Hyperemesis Syndrome: A Case Study in a Tunisian Young Man

    DesfavorávelMetanáliseDorEfeitos Adversos da CannabisNáusea e Vômito+1
  60. 2021

    Cannabinoid interventions for improving cachexia outcomes in cancer: a systematic review and meta‐analysis

    InconclusivoMetanáliseCâncerCaquexiaTHC FarmacêuticoTHC:CBD Farmacêutico
  61. 2021

    Cannabinoid metabolites as inhibitors of major hepatic CYP450 enzymes, with implications for cannabis-drug interactions

    DesfavorávelEstudo LaboratorialEfeitos Adversos da CannabisInsuficiência HepáticaCanabinol (CBN)
  62. 2021

    Cannabinoid Quinones—A Review and Novel Observations

    FavorávelMetanáliseCâncerInflamaçãoEstresse OxidativoCanabinoides Sintéticos HU-xCanabinol (CBN)+7
  63. 2021

    Cannabinoid receptor 1 expression is higher in muscle of old vs. young males, and increases upon resistance exercise in older adults

    FavorávelMetanáliseCondições GeriátricasSarcopenia
  64. 2021

    Cannabinoid Receptor 1 Inhibition in Chronic Kidney Disease: A New Therapeutic Toolbox

    FavorávelMetanáliseDoença Renal CrônicaEndocanabinoide (não especificado)
  65. 2021

    Cannabinoid Receptor 2 Agonism is Capable of Preventing Lipopolysaccharide Induced Decreases of Cochlear Microcirculation - A Potential Approach for Inner Ear Pathologies

    FavorávelEstudo em AnimaisInflamaçãoOtite MédiaCanabinoide Sintético (não especificado)Canabinoides Sintéticos JWH-x
  66. 2021

    Cannabinoid receptor agonists from Conus venoms alleviate pain-related behavior in rats

    FavorávelEstudo em AnimaisDorDor — Crônica
  67. 2021

    Cannabinoid receptor CB2 ablation protects against TAU induced neurodegeneration

    InconclusivoEstudo em AnimaisDoenças NeurodegenerativasDoença de Alzheimer
  68. 2021

    Cannabinoid receptor type 2 gene is associated with comorbidity of schizophrenia and cannabis dependence and fatty acid amide hydrolase gene is associated with cannabis dependence in the Spanish population

    DesfavorávelEnsaio ClínicoEfeitos Adversos da CannabisDependência — CannabisPsicoseEndocanabinoide (não especificado)Hidrolase de Amidas de Ácidos Graxos (FAAH)+1
  69. 2021

    Cannabinoid Receptors Overexpression in a Rat Model of Irritable Bowel Syndrome (IBS) after Treatment with a Ketogenic Diet

    FavorávelEstudo em AnimaisSíndrome do Intestino IrritávelDieta
  70. 2021

    Cannabinoid Signaling in Auditory Function and Development

    FavorávelMetanáliseZumbidoPerda AuditivaEndocanabinoide (não especificado)Canabinoide Sintético (não especificado)
  71. 2021

    Cannabinoid signalling and effects of cannabis on the male reproductive system

    InconclusivoMetanáliseInfertilidade MasculinaLibidoDisfunção ErétilEndocanabinoide (não especificado)
  72. 2021

    Cannabinoid Signalling in Immune-Reproductive Crosstalk during Human Pregnancy

    DesfavorávelMetanáliseGestação
  73. 2021

    Cannabinoid tetrad effects of oral Δ9-tetrahydrocannabinol (THC) and cannabidiol (CBD) in male and female rats: sex, dose-effects and time course evaluations

    InconclusivoEstudo em AnimaisDorDor — Aguda
  74. 2021

    Cannabinoid treatment for autism: a proof-of-concept randomized trial

    FavorávelEnsaio Clínico Duplo-CegoAutismo
  75. 2021

    Cannabinoid use and effects in patients with epidermolysis bullosa: an international cross-sectional survey study

    FavorávelMetanáliseEpidermólise Bolhosa
  76. 2021

    Cannabinoid use and self-injurious behaviours: A systematic review and meta-analysis

    DesfavorávelMetanáliseTentativa de Suicídio
  77. 2021

    Cannabinoid Use for Appetite Stimulation and Weight Gain in Cancer Care: Does Recent Evidence Support an Update of the European Society for Clinical Nutrition and Metabolism Clinical Guidelines?

    InconclusivoMetanáliseCâncerAnorexia (perda de apetite)Caquexia
  78. 2021

    Cannabinoid Use in a Tertiary Headache Clinic: A Cross-Sectional Survey

    FavorávelMetanáliseDorDor — Crônica
  79. 2021

    Cannabinoids and bladder symptoms in multiple sclerosis

    FavorávelMetanáliseDorAnsiedadeDor — Crônica+5
  80. 2021

    Cannabinoids and myocardial ischemia: Novel insights, updated mechanisms, and implications for myocardial infarction

    DesfavorávelMetanáliseDoenças Cardiovasculares (DCV)InfartoAterosclerose
  81. 2021

    Cannabinoids and orthopedic surgery: a systematic review of therapeutic studies

    FavorávelMetanáliseDorDor — Aguda
  82. 2021

    Cannabinoids and Pain: The Highs and Lows

    FavorávelMetanáliseDorDor — Crônica
  83. 2021

    Cannabinoids and the eye

    InconclusivoMetanáliseDorInflamaçãoGlaucoma+3
  84. 2021

    Cannabinoids as Key Regulators of Inflammasome Signaling: A Current Perspective

    FavorávelMetanáliseInflamaçãoCOVID-19Anandamida (AEA)2-Araquidonoilglicerol (2-AG)+3
  85. 2021

    Cannabinoids Drugs and Oral Health-From Recreational Side-Effects to Medicinal Purposes: A Systematic Review

    InconclusivoMetanáliseDorCâncerInflamaçãoAnandamida (AEA)2-Araquidonoilglicerol (2-AG)+8
  86. 2021

    Cannabinoids for Agitation in Alzheimer's Disease

    FavorávelMetanáliseDoença de AlzheimerDemência
  87. 2021

    Cannabinoids for major neurocognitive disorder: case report and literature review

    FavorávelMetanáliseDoenças Neurodegenerativas
  88. 2021

    Cannabinoids for SARS-CoV-2 and is there evidence of their therapeutic efficacy?

    FavorávelMetanáliseCOVID-19
  89. 2021

    Cannabinoids for skin diseases and hair regrowth

    InconclusivoMetanáliseQueda de CabeloCrescimento Anormal de PelosAnandamida (AEA)2-Araquidonoilglicerol (2-AG)
  90. 2021

    Cannabinoids for the treatment of dementia

    InconclusivoMetanálise ClínicaDisfunção CognitivaInsônia e Distúrbios do SonoDoença de AlzheimerCanabinoide Sintético (não especificado)THC Farmacêutico+3
  91. 2021

    Cannabinoids for the Treatment of Opioid Use Disorder: Where is the Evidence?

    FavorávelMetanáliseDependência QuímicaDependência — Opioides
  92. 2021

    Cannabinoids for the treatment of refractory neuropathic pruritus in amyotrophic lateral sclerosis: A case report

    FavorávelMetanáliseDoenças de PeleEsclerose Lateral Amiotrófica (ELA)PruridoTHC:CBD Farmacêutico
  93. 2021

    Cannabinoids in Audiogenic Seizures: From Neuronal Networks to Future Perspectives for Epilepsy Treatment

    FavorávelMetanáliseEpilepsiaEndocanabinoide (não especificado)
  94. 2021

    Cannabinoids in dermatologic surgery

    FavorávelMetanáliseDorInflamaçãoDor — Aguda+1
  95. 2021

    Cannabinoids in glioblastoma multiforme-hype or hope?

    FavorávelMetanáliseCâncerCâncer — Cérebro
  96. 2021

    Cannabinoids in Neurologic Illnesses

    InconclusivoMetanáliseDoenças Neurodegenerativas
  97. 2021

    Cannabinoids in the landscape of cancer

    FavorávelMetanáliseCâncerCanabinoide Sintético (não especificado)
  98. 2021

    Cannabinoids in the management of frontotemporal dementia: a case series

    FavorávelMetanáliseDoença de AlzheimerDemênciaTOC
  99. 2021

    Cannabinoids in Urology. Which Benign Conditions Might They Be Appropriate to Treat: A Systematic Review

    InconclusivoMetanáliseCistiteIncontinência Urinária
  100. 2021

    Cannabinoids modulate food preference and consumption in Drosophila melanogaster

    FavorávelEstudo em AnimaisObesidadeSíndrome MetabólicaAnandamida (AEA)2-Araquidonoilglicerol (2-AG)+5